▲ Peaking
Business
FDA approves Otsuka’s ADHD drug Simtriyo, teeing up its ‘next major CNS launch’
Otsuka receives FDA approval for Simtriyo, establishing a new drug class for the treatment of ADHD.
Simtriyo
1 trends tracked about this subject — the full history, oldest to newest below.